深圳市眼科医院是深圳市唯一一家三级甲等市属公立眼科专科医院

国家住院医师规范化培训联合培养单位

医院眼科是国家临床重点专科建设单位

广东省首批高水平临床重点专科

建有广东省眼与视觉工程技术研究中心

深圳市眼科智能诊疗装备和创新药物概念验证中心

连续7年保持"国考"等级A的好成绩

2020年度全国排名第八（其他专科手术组）

累计引进11个“三名工程”高层次医学团队

为契合医院高质量发展需求，深圳市眼科医院面向社会公开招聘博士后

眼科专家导师齐“坐镇”，快来Pick你的心选导师！

一、导师简介

迟玮

深圳市眼科医院院长

教授、主任医师

深圳市眼科医院 南方医科大学深圳眼科医学中心院长、党委副书记，博士研究生导师，医学博士、美国Baylor医学院博士后，全球前2%顶尖科学家，全国五一劳动奖章、广东省杰出青年医学人才、全国百篇优秀博士论文提名奖获得者等。

从事眼科临床和科研工作20余年，长期致力于眼底病、葡萄膜炎等重要致盲眼病的临床诊疗和玻璃体视网膜及白内障手术。诊治患者二十余万人，遍布全国及国际港澳台。聚焦重大致盲眼病的精准诊疗、人工智能、脑机接口等前沿领域，开展原创性、引领性科技攻关。创建了致盲率最高的眼病的早期诊断方法，推动该类疾病的致盲率由33%大幅降低到5.2%。开发了可替代较大副作用激素类药物的靶向溶酶体降解药物和抗纤维化多肽药物，多肽药物已进入临床2期。开发了AI眼底病诊疗大模型及10余个眼病诊断模型，创建了眼健康人工智能诊疗中心，为全国11个省369余家医院、22万人次进行AI眼病诊疗，有力推动了优质眼科医疗资源的跨区域下沉与标准化输出。对标马斯克的Neuralink公司牵头成功完成国内首个无线百通道视皮层假体（视皮层脑机接口）灵长类动物的视觉重建、开发了国际领先的“多模态眼功能成像仪”，实现“眼-脑-心”等慢性系统性疾病的早筛。

主持国家及省部级科研项目共20项，包括国家重点研发项目（首席科学家）、国自然重点项目、国自然区域联合重点项目、国自然面上项目等国家级基金项目6项及省部级基金14项。

发表SCI论文101篇，其中以通讯/第一作者发表SCI64篇，影响因子大于10分以上的18篇，包括Nat Genetics、Mol Cell、Nat Commun、PNAS、J Allergy Clin Immunol、BMJ、Mol Neurodeger、J Am Chem Soc、Prog Retin Eye Res、Adv Sci等权威医学期刊。

作为主要完成人之一共同制定了首个由中国人制定的眼病国际诊断标准，打破眼病诊断标准欧美制定的垄断局面。牵头/参与制定国际指南2部，国内指南15部，专家共识9部。主编及参编学术论著10部。相关成果荣获广东省科技进步奖一等奖、五洲女子科技奖；并作为主要完成人获国家科学技术进步奖二等奖、中华医学会科技奖一等奖、教育部科技进步奖一等奖等多项殊荣。

所获奖励

· 全国五一劳动奖章

· 广东省科技进步一等奖

· 全国百篇优秀论文提名奖获得者

· 广东省杰出青年医学人才（第一届）

· 中国女医师协会五洲女子科技奖-临床医学科研创新奖

· 作为主要参与人获得：国家科学技术进步奖二等奖、中华医学会科技奖一等奖、教育部科技进步奖一等奖、广东省科技进步奖一等奖、重庆市科技进步奖一等奖

· 广东省优秀博士学位论文

通讯/第一作者发表论文

1. Jiang S, Liu X, Zhang Z, Yang M, Zhu X, Ma L, Zhao L, Ling X, Zhou Z, Wu Z, Qu J, Li H, Liang J, Deng Z, Tian Q, Huang X, Huang X, Tan J, Sun J, Wang J, Guallar D, Das PP, Pinello L, Wang L, Wu H, Huang DF, Wang J, Lin H, Bai J, Fan L, Chi W*（共同通讯）, Xiao X, Ding J. JMJD2 regulates enhancer-promoter interactions via biomolecular condensate formation. Nat Genet（IF:29）. 2025 Dec 16. doi: 10.1038/s41588-025-02415-8. Epub ahead of print. PMID: 41402457.

2. Li X, Xu J, Yan X, Zhong J, Hou C, Xiao C, Niu L, Chi W*（通讯作者）. High-throughput capture of actively transcribed region-interacting sequences reveals an intricate promoter-centered regulatory network. Mol Cell(IF:16.6). 2025 Nov 18:S1097-2765(25)00859-7. doi: 10.1016/j.molcel.2025.10.018. Epub ahead of print. PMID: 41260212.

3. Li Y, Sun Y, Xie D, Chen H, Zhang Q, Zhang S, Wen F, Ou JS, Zhang M, Su L, Li X, Wen WP, Chi W*（通讯作者）. AIP1 Regulates Ocular Angiogenesis Via NLRP12-ASC-Caspase-8 Inflammasome-Mediated Endothelial Pyroptosis. Adv Sci (Weinh) (IF:14.3). 2024 Nov 11:e2405834.

4. Sun Y#, Li F#, Liu Y, Qiao D, Yao X, Liu GS, Li D, Xiao C, Wang T, Chi W*（通讯作者）. Targeting inflammasomes and pyroptosis in retinal diseases-molecular mechanisms and future perspectives. Prog Retin Eye Res (IF:17.8). 2024 Apr 22:101263.

5. Hu Y#, Hu Y#, Xiao Y#, Wen F, Zhang S, Liang D, Su L, Deng Y, Luo J, Ou J, Lu M, Hong Y, Chi W* （通讯作者）. Genetic landscape and autoimmunity of monocytes in developing Vogt-Koyanagi-Harada disease. Proc Natl Acad Sci USA（IF：11.1）. 2020;117(41):25712-25721.

6. Chen H#, Deng Y, Gan X, Li Y, Huang W, Lu L, Wei L, Su L, Luo J, Zou B, Hong Y, Cao Y, Liu Y* , Chi W*（通讯作者）. NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma. Mol Neurodeger (IF:15.1). 2020;15:26.

7. Chen HX, Liu ZD, Bai X, Wu B, Song R, Yao HC, Chen Y, Chi W*（共同通讯）, Hua Q, Cheng L, Xiao CL. Accurate cross-species 5mC detection for Oxford Nanopore sequencing in plants with DeepPlant. Nat Commun （IF:14.7）. 2025 Apr 4;16(1):3227.

8. Hua X#, Yuan X#, Li Y, Chen H, Yuan J, Tanumiharjo S, Bian F, Su L, Hong Y, Liu Y*, Chi W*（通讯作者）.Desiccating stress worsens alkali burn injury by magnifying caspase-8-induced imbalance of NLRP3 and NLRP6. J Allergy Clin Immunol（IF:14.2，临床免疫排名第一的杂志）. 2017; 140(4):1172-1176.

9. Chi W#（第一作者）， Li F#, Chen H#, Wang Y#, Zhu Y, Yang X, Zhu J, Wu F, Ouyang H, Ge J, Weinreb RN, Zhang K*, Zhuo Y*. Caspase-8 promotes NLRP1/NLRP3 inflammasome activation and IL-1β production in acute glaucoma. Proc Natl Acad Sci USA（IF：11.1）. 2014; 111(30):11181-6.

10. Chi W#（第一作者）, Hua X, Chen X, Bian F, Yuan X, Zhang L, Wang X, Chen D, Deng R, Li Z, Liu Y*, de Paiva CS, Pflugfelder SC, Li DQ*. Mitochondrial DNA oxidation induces imbalanced activity of NLRP3/NLRP6 inflammasomes by activation of caspase-8 and BRCC36 in dry eye. J Autoimmun (IF:12.8). 2017;80:65-76.

11. Chi W# （第一作者）， Yang P*, Li B, Wu C, Jin H, Zhu X, Chen L, Zhou H, Huang X, Kijlstra A. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol (IF:14.2，临床免疫排名第一的杂志). 2007; 119(5):1218-24.

12. Zhao J, Zhang J, Liu Y, Wang L, Huang C, Chi W*(共同通讯）, An M. PDZK1 Protects Against RPE Senescence by Targeting the 14-3-3ε-mTOR Axis to Attenuate Early Diabetic Retinopathy. Adv Sci (Weinh)(IF:14.3). 2025 Aug 25:e11288. doi: 10.1002/advs.202511288. Epub ahead of print. PMID: 40853330.

13. Dai Y#，Chi W*（通讯作者）. Purtscher-like retinopathy as a first manifestation of systemic lupus erythematosus. Brit Med J (IF:105.7). 2018; 360:j5551.

14. Li Q#, Hua X#, Li L, Zhou X, Tian Y, Deng Y, Zhang M, Yuan X*, Chi W*（通讯作者）. AIP1 suppresses neovascularization by inhibiting the NOX4-induced NLRP3/NLRP6 imbalance in a murine corneal alkali burn model. Cell Commun Signal. (IF:8.4)2022 May 6;20(1):59.

15. Hang Zhang, Kan Xu, Jia-Hui Wu, Dijie Qiao, Xiang-Yu Tan, Sun Rong, Bingwu Wang, Xi-Long Leng, Ke Wang, Hao-Ling Sun, Song Gao, Wei Chi*（共同通讯）, Jun-long Zhang*. Antiferromagnetic Dimanganese Catalase Mimics: Targeting Oxidative Stress to Mitigate Corneal Neovascularization Post-alkali Injury. Journal of the American Chemical Society (IF:15.41). August 15, 2025. doi:10.1021/jacs.5c08110

16. Tang X, Luo N, Chen C, Wu P, Guo W, Shen Y, Jiang J, Fu M, Huo L, Mu J, Liu M, Liu G, Zhang S, Pan X, Chi W*（通讯作者）. Construction of virtual whole eye model based on ultra-widefield optical coherence tomography in myopia. NPJ Digit Med (IF:15.1). 2026 Mar 2. doi: 10.1038/s41746-026-02376-0. Epub ahead of print. PMID: 41772254.

17. Ye X, Liu Y, Chen C, Sun Y, Li F, Fu Y, Luo J, Su L, Chi W*（通讯作者）. A novel function and mechanism of ischemia-induced retinal astrocyte-derived exosomes for RGC apoptosis of ischemic retinopathy. Mol Ther Nucleic Acids (IF:7.6). 2024 May 7;35(2):102209.

18. Chen H#, Gan X#, Li Y#, Gu J, Liu Y, Deng Y, Wang X, Hong Y, Hu Y, Su L, Chi W*（通讯作者）. NLRP12- and NLRC4-mediated corneal epithelial pyroptosis is driven by GSDMD cleavage accompanied by IL-33 processing in dry eye. Ocul Surf (IF:12).  2020 Oct;18(4):783-794.

19. Zhang L, Sun Y, Yao X, Yan C, Liu Y, Qiao D, Du Z, Hu C, Guo F, Meng Z, Chi W*（通讯作者）. Single-cell transcriptomic profiling reveals aberrant CD4⁺ naive T cell differentiation driving immune activation in Behçet's uveitis. J Transl Med（IF:7.5）. 2025 Dec 2. doi: 10.1186/s12967-025-07520-0. Epub ahead of print. PMID: 41331613.

20. Liu LR, Zhong JY, Bai X, Ye CL, Hou C, Ding J, Chi W*(共同通讯）, Xiao CL, Niu L. Single-molecule chromatin profiling reveals cell type-specific A/B compartment alteration and multi-enhancer transcriptional coordination. J Genet Genomics（IF:7.1）. 2025 Oct 8:S1673-8527(25)00275-9. doi: 10.1016/j.jgg.2025.09.011. Epub ahead of print. PMID: 41072791.

21. Chi W#（第一作者）, Chen H#, Li F, Zhu Y, Yin W, Zhuo Y*. HMGB1 promotes the activation of NLRP3 and caspase-8 inflammasomes via NF-κB pathway in acute glaucoma. J Neuroinflammation (IF:10.1). 2015;12:137.

22. Liang J, Wu B, Hei X, Chen L, Ji Y, Tang X, Feng L, Guo F, Zheng H, Diao Y, Xie T, Zou Z, Fang D, Chi W*（共同通讯）, Zhang S. Linking Mitochondrial Gene Dysregulation to Immune Cell Shifts in Retinitis Pigmentosa. Mol Neurobiol. 2025 Nov 24;63(1):164. doi: 10.1007/s12035-025-05564-3. PMID: 41286208; PMCID: PMC12644131.

23. Lu M#, Wang X#, Lei L#, Deng Y, Yang T, Dai Y, Li Y, Gan X, Hu Y, Chen H, Li M, Su L, Yuan J, Chi W*（通讯作者）. Quantitative Analysis of Anterior Chamber Inflammation Using the Novel CASIA2 Optical Coherence Tomography. Am J Ophthalmol. 2020;216:59-68.

24. Chen H#, Li Y, Gu J, Yin L, Bian F, Su L, Hong Y, Deng Y, Chi W* （通讯作者）. TLR4-MyD88 pathway promotes the imbalanced activation of NLRP3/NLRP6 via caspase-8 stimulation after alkali burn injury. Exp Eye Res. 2018; 176:59-68.

25. Chi W#（第一作者）, Zhu X#, Yang P*, Liu X, Lin X, Zhou H, Huang X, KijlstraA. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis.Invest Ophthalmol Vis Sci. 2008; 49(7):3058-64.

26. He X, Wang Y, Zhang X*, Chi W*（共同通讯）, Yang W*. Artificial intelligence in pathologic myopia: a review of clinical research studies. Front Med (Lausanne). 2025 Apr 23;12:1572750.

27. Lv X, Yang Y, Wan C, Zhao J, Chi W*（共同通讯）, Yang W. Automated cup-to-disc ratio quantification via color fundus photography for chronic glaucoma screening. BMC Med Imaging（IF:3.2）. 2025 Oct 28;25(1):429. doi: 10.1186/s12880-025-01981-x. PMID: 41152744; PMCID: PMC12560540.

28. Sun Y#, Wen F#, Chun Y, Su L, Luo J, Chi W*（共同通讯）， Zhang S*.Mitophagy Protects the Retina Against Anti-Vascular Endothelial Growth Factor Therapy-Driven Hypoxia via Hypoxia-Inducible Factor-1α Signaling. Front Cell Dev Biol. (IF:5.5) 2021.9:727822.

29. Wu J, Yang Y, Wan C, Yang M, Yang W, Chi W*（通讯作者）.Dual U-Net with multi-task attention for automated eyelid curvature quantification. Front Med (Lausanne). 2025 Jul 17;12:1631468.

30. Ye X#, Zhang H#, Xiao P, Wang G, Hu X, Yan C, Li F, Hu Y, Su L, Luo J, Yuan J*, Wen F*, Chi W*（通讯作者）. Microvasculature Features of Vogt-Koyanagi-Harada Disease Revealed by Widefield Swept-Source Optical Coherence Tomography Angiography. Front Med (Lausanne). (IF:3.9). 2021 Oct 14;8:719593.

31. Yan C#, Li F#, Hou M#, Ye X, Su L, Hu Y, Luo J, Chi W*（通讯作者）. Vascular Abnormalities in Peripapillary and Macular Regions of Behcet's Uveitis Patients Evaluated by Optical Coherence Tomography Angiography. Front Med (Lausanne). (IF:3.9) 2021 Sep 16;8:727151.

32. Deng Y#, Fu Y#, Sheng L#, Hu Y, Su L, Luo J, Yan C, Chi W*（通讯作者）. The Regulatory NOD-Like Receptor NLRC5 Promotes Ganglion Cell Death in Ischemic Retinopathy by Inducing Microglial Pyroptosis. Front Cell Dev Biol. (IF:5.5) 2021 May 20;9:669696.

33. Fang D, Hei X, Lu C, Liang J, Pan C, Xiao P, Wang H, Diao Y, Zheng H, Liang R, Zhang J, Zhang S, Chi W*（通讯作者）. Longitudinal assessment of cone structure and lesion remodeling in laser-induced retinopathy. Asia Pac J Ophthalmol (Phila)（IF:4.5）. 2026 Apr 26:100325. doi: 10.1016/j.apjo.2026.100325. Epub ahead of print. PMID: 42049112.

34. Li Q#, Pang J#, Deng Y#, Zhang S, Wang Y, Gao Y, Yuan X, Wei Y, Zhang H, Tan J, Chi W*（共同通讯）， Guo W*. Adverse Cardiovascular Effects of Phenylephrine Eye Drops Combined With Intravenous Atropine. Front Pharmacol. 2021 Jan 27;11:596539.

35. Huang XF#, Chi W#（共同第一）, Lin D#, Dai ML, Wang YL, Yang YM, Jin ZB*, Wang Y*. Association of IL33 and IL1RAP Polymorphisms With Acute Anterior Uveitis. Curr Mol Med. 2018 Mar 9;17(7):471-477.

36. Luo K#, Cai H#, Hu Y#, Jin C, Gan X, Deng Y, Lu M, Chen H,Su L, Chen G, Chi W*（通讯作者）. Distinguishing Microvasculature Features of Vogt-Koyanagi-Harada in Patients in Acute and Convalescent Phases Using Optical Coherence Tomography Angiography. Ocul Immunol Inflamm.  2021 Apr 3;29(3):465-471

37. Hua X#, Dong Y, Wang L, Li Z, Du J, Chi W*（共同通讯）, Yuan X*. Intraocular lens implantation performed first to protect the posterior capsule in morgagnian cataracts during phacoemulsification. Int J Ophthalmol. 2019, 18;12(7):1215-1218.

38. Chen H#, Chi W#* （共同第一兼共同通讯作者）, Cai X, Deng Y, Jiang X, Wei Y, Zhang S*. Macular microvasculature features before and after vitrectomy in idiopathic macular epiretinal membrane: an OCT angiography analysis. Eye (Lond). 2019; 33(4):619-628.

39. Deng Y#, Zhong Q, Zhang A, Cai X, Lu M, Zhang S, Su L, Chen H, Lin Y, Sun L, Chen G, Zhong L, Jin C* and Chi W* （通讯作者）. Microvascular changes after conbercept therapy in central retinal vein occlusion analyzed by optical coherence tomography angiography. Int J Ophthalmol. 2019 18;12(5):802-808.

40. Deng Y#, Cai X#, Zhang S, Su L, Chen H, Lin Y, Sun L, Chen G, Zhong L, Jin C and Chi W* （通讯作者）. Quantitative Analysis of Retinal Microvascular Changes after Conbercept Therapy in Branch Retinal Vein Occlusion using Optical Coherence Tomography Angiography. Ophthalmologica. 2019;21:1-12.

41. Hao X#, Yi C, Wang Y, Li J, Huang F, He L, Chi W* （通讯作者）. Identification of intraocular inflammatory mediators in patients with endophthalmitis. Mol Vis. 2016; 22:563-74.

42. Chi W#（第一作者）, Yang P*, Zhu X, Wang Y, Chen L, Huang X, Liu X. Production of interleukin-17 in Behcet's disease is inhibited by cyclosporin A. Mol Vis. 2010; 16:880-6.

43. Hua X#, Chi W*（共同通讯作者）, Su L, Li J, Zhang Z, Yuan X*. ROS-induced Oxidative Injury involved in Pathogenesis of Fungal Keratitis via p38 MAPK Activation.Sci Rep. 2017; 7(1):10421.

44. Qu Y#, Chi W#（共同第一作者）, Hua X, Deng R, Li J, Liu Z, Pflugfelder SC, Li DQ*. Unique expression pattern and functional role of periostin in human limbal stem cells. PLoS One. 2015; 10(2):e0117139.

45. Chi W#* （第一兼通讯作者）, Zhou S, Yang P, Chen L. CD4⁺ T cells from behcet patients produce high levels of IL-17. Eye Sci. 2011 Jun; 26 (2):65-9.

46. Chi W#（第一作者）, Li A, Wang S, Zhu X. Efficacy of combined administration of 0.2% brimonidine and 0.5% betaxolol in treatment of primary open angle glaucoma and ocular hypertension. Eye Sci. 2013; 28(4):190-4.

47. Meng Y, Li F, Zeng S, Liang C, Chi W* (通讯作者). Global, Regional, and National Burden of Trachoma: Cross-Country Inequalities, 1990-2021, with Projections to 2040. Ophthalmol Ther. 2025 May;14(5):1065-1079.

48. Huang J,Jin C, Lin D, Zhu X, Chen Y, Tao Z, Wu J, Chi W* (共同通讯), Wang Y. Diagnostic Challenges in Fuchs’ Uveitis Syndrome in China: A Multi-Center Comparative Study of Three Criteria. Ocul Immunol Inflamm. 2025 Aug;33(6):935-940.

49. Zhang P, Zhang Q, Hu X, Chi W* (共同通讯), Yang W. Research Progress in Artificial Intelligence for Central Serous Chorioretinopathy: A Systematic Review. Ophthalmol Ther. 2025 Jul 22. doi: 10.1007/s40123-025-01209-9.

50. Yuan F, Li H, Yang J, Li W, Zhao K, Luo L, Fang X, Wang J, Chi W*(共同通讯）, Zeng K. Associations between ocular parameters and corneal astigmatism in young Chinese adults: a cross-sectional study. BMC Ophthalmol（IF:1.7）. 2025 Sep 30;25(1):512. doi: 10.1186/s12886-025-04339-7. PMID: 41029564; PMCID: PMC12487187.

51. Huang M, Wang X, Zhou S, Cui X, Zhang Z, Xu Y, Yang W, Chi W*(通讯作者）. Comparative performance of large language models for patient-initiated ophthalmology consultations. Front Public Health（IF:3.4）. 2025 Sep 22;13:1673045. doi: 10.3389/fpubh.2025.1673045. PMID: 41059182; PMCID: PMC12497754.

52. Cheng WY, Rong WN, Li HP, Wang XG, Qi R, Qi XL, Sheng XL, Chi W*(通讯作者）. Early Onset High Myopia and Severe Anisometropia Associated With Familial Exudative Vitreoretinopathy of Irregular Dominant Inheritance in 11 Chinese Families: Analysis of Refraction Features and Pathogenic Variations. Genet Res (Camb)（IF：2.1）. 2025 Dec 29;2025:9963550. doi: 10.1155/genr/9963550. PMID: 41477247; PMCID: PMC12748083.

53. Xu J, Liu Q, Shen J, Tan R, Tian S, Chi W*(共同通讯）, Yang W. Image-text guided fundus vessel segmentation via attention mechanism and gated residual learning. Front Cell Dev Biol（IF:4.3）. 2025 Dec 16;13:1710343. doi: 10.3389/fcell.2025.1710343. PMID: 41476610; PMCID: PMC12748172.

54. Wei JW, Zhang Q, Wang XY, Huang MX, Gan JH, Yang WH, Chi W*（通讯作者）. Advances in the application of virtual reality technology in ophthalmic surgical skills training. Int J Ophthalmol（IF:1.8）. 2026 Feb 18;19(2):393-404. doi: 10.18240/ijo.2026.02.23. PMID: 41572988; PMCID: PMC12820628.

55. Liao X, Lou J, Liu C, Wang Y, Zhu G, Ke Y, Bai M, Yang P, Yang W,  Chi W*（通讯作者）. Advancements in OCT and OCTA Imaging for AMD: An In-depth Analysis of Research Hotspots, Emerging Trends, and Technological Innovations. Photodiagnosis Photodyn Ther（IF:2.6）. 2026 Feb 17:105402. doi: 10.1016/j.pdpdt.2026.105402. Epub ahead of print. PMID: 41713794.

56. Zhang P, Wang J, Hu X, Wang X, Fan X, Chi W*（共同通讯）, Yang W. Comparative performance of GPT-4, GPT-o3, GPT-5, Gemini-3-Flash, and DeepSeek-R1 in ophthalmology question answering. Front Cell Dev Biol（IF:4.3）. 2026 Jan 29;14:1744389. doi: 10.3389/fcell.2026.1744389. PMID: 41695391; PMCID: PMC12894337.

57. Yang W, Fang H, Xu Y, Chi W*（通讯作者）. Editorial: Artificial intelligence applications in chronic ocular diseases, volume II. Front Cell Dev Biol（IF:4.3）. 2026 Feb 24;14:1762437. doi: 10.3389/fcell.2026.1762437. PMID: 41816111; PMCID: PMC12972933

58. Jin A, Zhang R, Fan X, Li F, Feng Y, Zeng L, Wang J, Liu D, Chi W*（共同通讯）, Fan N. Accelerometer-derived moderate-to-vigorous physical activity patterns and incident dry eye disease: a prospective UK Biobank cohort study. BMC Public Health（IF:3.6）. 2026 Feb 27. doi: 10.1186/s12889-026-26795-6. Epub ahead of print. PMID: 41761185.

59. Wu B, Chen Y, Zhou Y, Niu L, Chen HX, Li Y, Zhong JY, Zhao S, Chi W*（共同通讯）, Zhang Y, Xiao CL. Z-Calling: a tool for A/Z (2,6-diaminopurine) base calling and dZ-DNA detection using PacBio HiFi reads. Commun Biol（IF:5.1）. 2026 Mar 13. doi: 10.1038/s42003-026-09849-8. Epub ahead of print. PMID: 41826500.

60. Jiang Z, Bai B, Diao Y, Du Y, Li B, Wang B, Zhou L, Liu Z, Feng L, Chen L, Chi W*（通讯作者） . Endoscopic dacryocystorhinostomy with and without silicone intubation in primary acquired nasolacrimal duct obstruction: a comparative study. BMC Ophthalmol（IF:1.7）. 2026 Mar 25. doi: 10.1186/s12886-026-04752-6. Epub ahead of print. PMID: 41882630.

61. Yan Z, Chi W*（共同通讯）, Yan Z, Wang H. Metformin attenuates TBHP-induced oxidative injury in human lens epithelial cells and is associated with SIRT1/FOXO1-related autophagy. PLoS One（IF:2.6）. 2026 Apr 7;21(4):e0346822. doi: 10.1371/journal.pone.0346822. PMID: 41945556; PMCID: PMC13056204.

62. Liang J, Zou Z, Chen L, Hei X, Diao Y, Feng L, Zhuang Y, Li W, Zheng H, Xiao P, Lin Q, Pan C, Zhang J, Chi W*（共同通讯）, Fang D, Zhang S. Cone structure and retinal sensitivity assessment in patients with red-green colour vision deficiency using multimodal imaging. Br J Ophthalmol（IF:3.5）. 2026 Apr 24:bjo-2025-329412. doi: 10.1136/bjo-2025-329412. Epub ahead of print. PMID: 42031504.

二、薪酬待遇

1. 基础综合年薪总计约为50万至80万元，另可享受科研绩效奖励，并择优提供留院机会。

2.医院为在站博士后提供基础年薪与住房补贴。

3.符合条件的博士后人员在站期间可按以下情况给予在站生活补助之一:

（1）符合广东省海外博士后人才支持项目，来本市从事博士后工作的，给予每人60万元在站生活补贴;

（2）符合省在站博士后每人总额30万元生活补贴资助条件的，市财政给予每人12万元在站生活补助;

（3）其他人员，市财政给予每人36万元在站生活补助。

4.博士后人员期满出站后6个月内留（来）深全职工作且与企事业单位签订3年以上劳动（聘用）合同的，给予每人36万元出站留（来）深生活补助。

5.博士后进站后可自愿选择落户深圳市，申领落户补贴。

6.若博士后资助政策有所调整，以最新的文件规定为准。

招聘事项

三、招聘流程

（一）线上报名

本次招聘采用线上报名方式，公告长期有效。有意向报名博士后者请将个人简历发送至szykkjk@126.com（邮件主题标明为“应聘岗位+姓名+博士后招聘网”）

（二）资格审查和确定面试人选

（三）面试

（四）资格复审

（五）体检

（六）公示

（七）聘用

四、联系方式

科研教学部 张老师 0755-23959560

人力资源部 姜老师 0755-23959523

更多最新博士后招聘信息请关注博士后招聘网微信公众号（ID：boshihoujob）

原文出处：

https://mp.weixin.qq.com/s/YkuX36iJOfdeIa1KMPg1YQ

来源：深圳市眼科医院